No association of 6-sulfatoxymelatonin with in-bed 60-Hz magnetic field exposure or illumination level among older adults

Environmental Research

Volumn 89, Issue 3, 2002, Pages 201-209

  Youngstedt, Shawn D ^a   Kripke, Daniel F ^a   Elliott, Jeffrey A ^a   Assmus, Joseph D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Drugs; EMF; Light; Melatonin; Photoperiod

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; MELATONIN;

HEALTH RISK; POLLUTION EXPOSURE;

ADULT; AGED; AGING; ARTICLE; CANCER RISK; DRUG USE; FEMALE; HOME; HUMAN; ILLUMINATION; MAGNETIC FIELD; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NIGHT; PHOTOPERIODICITY; PRIORITY JOURNAL; URINALYSIS;

EID: 0036319162     PISSN: 00139351     EISSN: None     Source Type: Journal    
DOI: 10.1006/enrs.2002.4370     Document Type: Article

References (55)

1. A 50-Hz electromagnetic field impairs sleep
2. Low-dose interleukin-2 subcutaneous immunotherapy in association with the pineal hormone melatonin as a first-line therapy in locally advanced or metastatic hepatocellular carcinoma
3. Radioimmunoassay of 6-sulphatoxy melatonin using an iodinated tracer
4. Light attenuation by the human eyelid
5. Melatonin and 6-sulfatoxymelatonin circadian rhythms in serum and urine of primary prostate cancer patients: Evidence for reduced pineal activity and relevance of urinary determinations
6. Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome
7. Melatonin in relation to body measures, sex, age, season and the use of drugs in patients with major affective disorders and healthy subjects
8. Effects of melatonin on cancer: Studies on MCF-7 human breast cells in culture
9. The biological and behavioral effects of light in humans: From basic physiology to application
10. The relationship between electromagnetic field and light exposures to melatonin and breast cancer risk: A review of the relevant literature
11. Dose-response relationship between light irradiance and the suppression of plasma melatonin in human volunteers
12. Melatonin secretion related to side-effects of beta-blockers from the central nervous system
13. Melatonin metabolite levels in workers exposed to 60-Hz magnetic fields: Work in substations and with 3-phase conductors
14. Geomagnetic disturbances are associated with reduced nocturnal excretion of a melatonin metabolite in humans
15. Nocturnal excretion of a urinary melatonin metabolite among electric utility workers
16. Reduced excretion of a melatonin metabolite in workers exposed to 60 Hz magnetic fields
17. Melatonin/Progestin OC's: A method to prevent breast cancer?
18. Residential magnetic fields, light-at-night, and nocturnal urinary 6-sulphatoxymelatonin concentration in women
19. Night shift work, light at night, and risk of breast cancer
20. Examination of the melatonin hypothesis in women exposed at night to EMF or bright light
21. Human melatonin during continuous magnetic field exposure
22. Nocturnal melatonin levels in human volunteers exposed to intermittent 60 Hz magnetic fields
23. Midday exposure to bright light changes the circadian organization of plasma melatonin rhythm in humans
24. Suppression of melatonin by 2000-lux light in humans with closed eyelids
25. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture
26. Chronic exposure to ELF magnetic fields during night sleep with electric sheet: Effects on diurnal melatonin rhythms in men
27. Nocturnal 6-hydroxymelatonin sulfate excretion in female workers exposed to magnetic fields
28. Measuring temporal variability in residential magnetic field exposures
29. Modulation of cancer endocrine therapy by melatonin: A phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone
30. Magnetic fields and breast cancer: Experimental studies on the melatonin hypothesis
31. The immunoneuroendocrine role of melatonin
32. Overview of electromagnetic field exposure and dosimetry
33. A human phase-response curve to light
34. Nonsteroidal anti-inflammatory drugs affect normal sleep patterns in humans
35. Nonsteroidal anti-inflammatory drugs alter body temperature and suppress melatonin in humans
36. Evidence for the involvement of the visual system in mediating magnetic field effects on pineal melatonin synthesis in the rat
37. Bright light exposure during the daytime affects circadian rhythms of urinary melatonin and salivary immunoglobulin A
38. Alterations of the circadian melatonin rhythm by the electromagnetic spectrum: A study in environmental toxicology
39. A review of the evidence supporting melatonin's role as an antioxidant
40. Magnetic field effects on pineal indoleamine metabolism and possible biological consequences
41. Magnetic fields and pineal function in humans: Evaluation of nocturnal acute exposure to extremely low frequency magnetic fields on serum melatonin and urinary 6-sulfatoxymelatonin circadian rhythms
42. 6-Sulphatoxymetatonin production in breast cancer patients
43. The melatonin hypothesis: Electric power and breast cancer
44. Alcohol consumption and urinary concentration of 6-sulphatoxymelatonin in healthy women
45. Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer
46. Electrical wiring configuration and childhood cancer
47. The influence of age, sex, height, weight, urine volume and latitude on melatonin concentrations in urine multinational study
48. Circadian rhythmicity of man under the influence of weak electromagnetic fields
49. Evidence for an effect of ELF elctromagnetic fields on human pineal gland function
50. Changes in human plasma melatonin profiles in response to 50 Hz magnetic field exposure
51. Melatonin excretion is not related to sleep in the elderly
52. Circadian abnormalities in older adults